Avanos Medical Inc (NYSE: AVNS) is 7.98% higher on its value in year-to-date trading and has touched a low of $17.24 and a high of $24.77 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The AVNS stock was last observed hovering at around $24.14 in the last trading session, with the day’s gains setting it 0.08%.
Currently trading at $24.22, the stock is 4.33% and 10.46% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.2 million and changing 0.33% at the moment leaves the stock 18.65% off its SMA200. AVNS registered 14.30% gain for a year compared to 6-month gain of 29.10%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 1.98% loss in the last 1 month and extending the period to 3 months gives it a 21.65%, and is 2.50% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.35% over the week and 2.68% over the month.
Avanos Medical Inc (AVNS) has around 3771 employees, a market worth around $1.11B and $682.40M in sales. Current P/E ratio is 145.90 and Fwd P/E is 13.33. Profit margin for the company is 1.13%. Distance from 52-week low is 40.53% and -2.22% from its 52-week high. The company has generated returns on investments over the last 12 months (0.54%).
The EPS is expected to grow by 34.63% this year.
Avanos Medical Inc (AVNS) Top Institutional Holders
359.0 institutions hold shares in Avanos Medical Inc (AVNS), with institutional investors hold 97.34% of the company’s shares. The shares outstanding are 46.17M, and float is at 44.85M with Short Float at 1.63%. Institutions hold 94.56% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 7.01 million shares valued at $139.66 million. The investor’s holdings represent 15.1758% of the AVNS Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 5.27 million shares valued at $$104.98 million to account for 11.4072 of the shares outstanding. The other top investors are RGM CAPITAL, LLC which holds 3.17 million shares representing 6.8646% and valued at over $63.18 million, while DIMENSIONAL FUND ADVISORS LP holds 5.5793 of the shares totaling 2.58 million with a market value of $51.35 million.
Avanos Medical Inc (AVNS) Insider Activity
The most recent transaction is an insider sale by Greiner Michael,the company’sSVP – Chief Financial Officer. SEC filings show that Greiner Michael sold 8,000 shares of the company’s common stock on Mar 14 ’24 at a price of $19.12 per share for a total of $0.15 million. Following the sale, the insider now owns 0.15 million shares.
Avanos Medical Inc disclosed in a document filed with the SEC on Mar 11 ’24 that Shimer Julie Ann (Director) bought a total of 500 shares of the company’s common stock. The trade occurred on Mar 11 ’24 and was made at $19.85 per share for $9925.0. Following the transaction, the insider now directly holds 50090.0 shares of the AVNS stock.
